Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Biomedical Materials, Tianjin, China.
Clinical Laboratory, Tianjin Hospital, Tianjin, China.
Animal Model Exp Med. 2024 Oct;7(5):685-695. doi: 10.1002/ame2.12433. Epub 2024 May 24.
In facial plastic surgery, patients with nasal deformity are often treated by rib cartilage transplantation. In recent years, cartilage tissue engineering has developed as an alternative to complex surgery for patients with minor nasal defects via injection of nasal filler material. In this study, we prepared an injectable nasal filler material containing poly-L-lactic acid (PLLA) porous microspheres (PMs), hyaluronic acid (HA) and adipose-derived mesenchymal stem cells (ADMSCs).
We seeded ADMSCs into as-prepared PLLA PMs using our newly invented centrifugation perfusion technique. Then, HA was mixed with ADMSC-incorporated PLLA PMs to form a hydrophilic and injectable cell delivery system (ADMSC-incorporated PMH).
We evaluated the biocompatibility of PMH in vitro and in vivo. PMH has good injectability and provides a favorable environment for the proliferation and chondrogenic differentiation of ADMSCs. In vivo experiments, we observed that PMH has good biocompatibility and cartilage regeneration ability.
In this study, a injectable cell delivery system was successfully constructed. We believe that PMH has potential application in cartilage tissue engineering, especially in nasal cartilage regeneration.
在面部整形手术中,常通过肋软骨移植来治疗鼻畸形患者。近年来,软骨组织工程已发展成为一种替代方法,通过注射鼻填充物材料来治疗有轻微鼻缺损的患者,避免了复杂的手术。本研究我们制备了一种含有聚左旋乳酸(PLLA)多孔微球(PMs)、透明质酸(HA)和脂肪间充质干细胞(ADMSCs)的可注射性鼻填充材料。
我们使用新发明的离心灌注技术将 ADMSCs 接种到预制备的 PLLA PM 中。然后,将 HA 与 ADMSC 包埋的 PLLA PM 混合,形成亲水性和可注射的细胞输送系统(ADMSC 包埋的 PMH)。
我们评估了 PMH 的体外和体内生物相容性。Pmh 具有良好的可注射性,并为 ADMSCs 的增殖和软骨分化提供了有利的环境。体内实验观察到 PMH 具有良好的生物相容性和软骨再生能力。
本研究成功构建了一种可注射细胞输送系统。我们相信 PMH 在软骨组织工程中具有潜在的应用价值,特别是在鼻软骨再生方面。